Directorate Change

RNS Number : 5968H
Xtract Resources plc
04 August 2021
 

 

For immediate release

4 August 2021

 

Xtract Resources Plc

("Xtract" or the "Company")

Board Changes

 

The Board of Xtract Resources Plc ("Xtract" or the "Company") announces that Jeremy Read has stepped down as a non-executive director but will continue to act as Project Manager to the Bushranger Project.

The Board is grateful for Jeremy's contribution as a non-executive director and is very pleased that he will be able to continue to work closely with the Company on progressing the Bushranger Project which has entered an intensive phase of exploration activity. The Board and Jeremy are of the opinion that to focus on the Bushranger Project as Project Manager is in the best interests of the Company and the Project.

The Company intends shortly to appoint to the Board a corporate and financially experienced, independent non-executive director from the resources sector.

Further information is available from the Company's   website:  www.xtractresources.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018 ("UK MAR").

 

The person who arranged for the release of this announcement on behalf of the Company was Colin Bird, Director.

 

 

Enquiries :

 

Xtract Resources Plc

Colin Bird,

Executive Chairman

 

+44 (0)20 3416 6471

www.xtractresources.com

Beaumont Cornish Limited

Nominated Adviser and Joint Broker

Roland Cornish

Michael Cornish

Felicity Geidt

+44 (0)207628 3369

www.beaumontcornish.co.uk

 

Novum Securities Limited

Joint Broker  

 

Jon Belliss

Colin Rowbury 

 

+44 (0) 207 399 9427

www.novumsecurities.com  

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUAURUPGGWC
UK 100

Latest directors dealings